If you have been reading about incretin and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-09-09. Numbers and descriptions here follow the published literature rather than marketing material.
Purified material is typically handled as a lyophilized powder kept at or below minus twenty degrees Celsius, shielded from light and moisture. In that state the solid remains stable for extended periods, although repeated freeze-thaw cycling can encourage aggregation. Once dissolved, aqueous solutions are less durable and are generally held cold and used within a brief window. Buffer composition, pH and ionic strength all influence degradation rates, and mildly acidic to neutral conditions are commonly examined. Actual shelf life depends on formulation, concentration and container, so stability limits are established experimentally rather than assumed.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Visual inspection serves only as a preliminary check |
| Solubility | Freely soluble in water and aqueous buffers | Gentle mixing may be needed to reach full dissolution |
| Typical storage | Minus 20 degrees Celsius or colder, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Primary analytical method | Reversed-phase HPLC with mass detection | Purity reported as chromatographic area percent |
| Common synonyms | GIP/GLP-1 dual agonist; LY3298176 | Development codes are distinct from approved product names |
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.
Research-grade material circulates through suppliers that differ widely in documentation and testing practice, so a certificate of analysis is a starting point rather than proof of quality. Independent verification typically repeats chromatographic purity and mass confirmation on the received lot, and compares results against a retained reference standard. Regulatory status varies by jurisdiction, and a substance cleared as a medicine is not interchangeable with a research chemical of the same name. Open questions include how closely non-pharmaceutical lots match approved material in impurity profile and in aggregate content.
=== Pleurotus ostreatus === The commonly known fungal species, white-rot basidiomycetes, are capable of degrading polymeric carbohydrates and using them for growth. Pleurotus ostreatus is an edible white-rot fungus known to degrade cellulose, hemicellulose and lignin, hence reinforcing its potential to thrive on wastes such as wood, textile, and agricultural residues. The growth of P. ostreatus on textile residue and mycelium production was tested in the department of civil engineering in Ontario Canada. The conducted experiment proved the applicability of textile waste as a potential feedstock. However, the loss in biocomposite weight of 1%–5% has been further corroborated by the water loss in the sample and in fungal mycelium. Additionally, the maximum compressive strength was observed as 270 kPa using cotton-based biocomposite. Overall, a lightweight biocomposite was obtained which could be a potential alternative for polystyrene- based products. These findings show the ability of the fungus to thrive on polyester plastic in textiles and provide an alternative for converting this plastic material into bio-based materials. Additionally, by varying the mycelium growth, the plasticity and stiffness properties of the resultant biocomposite can be changed.
Insulated shipping containers are a type of packaging used to ship temperature sensitive products such as foods, pharmaceuticals, and chemicals. They are used as part of a cold chain to help maintain product freshness and efficacy.
Water is considered a purifier in most religions. Faiths that incorporate ritual washing (ablution) include Christianity, Hinduism, Islam, Judaism, the Rastafari movement, Shinto, Taoism, and Wicca. Immersion (or aspersion or affusion) of a person in water is a central Sacrament of Christianity (where it is called baptism); it is also a part of the practice of other religions, including Islam (Ghusl), Judaism (mikvah) and Sikhism (Amrit Sanskar). In addition, a ritual bath in pure water is performed for the dead in many religions including Islam and Judaism. In Islam, the five daily prayers can be done in most cases after washing certain parts of the body using clean water (wudu), unless water is unavailable (see Tayammum). In Shinto, water is used in almost all rituals to cleanse a person or an area (e.g., in the ritual of misogi). In Christianity, holy water is water that has been sanctified by a priest for the purpose of baptism, the blessing of persons, places, and objects, or as a means of repelling evil. In Zoroastrianism, water (āb) is respected as the source of life.
Sources: en.wikipedia.org
He received a B.S. in physics in 1943. He did not attend graduate school, instead deciding to join the Fighting Vehicles Research Establishment where he served between 1943 and 1947 developing tank fire-control systems.
=== Sales === The Valve Index headset, controllers, and base stations sold out in the US, Canada, and Europe within a week of the Alyx announcement. By mid-January 2020, they were sold out in all 31 regions. According to Superdata, Valve sold 103,000 Index units in the fourth quarter of 2019 as a result of the Alyx announcements, compared to the total 149,000 sold throughout 2019, and the Index was the highest-selling VR headset for PCs during that quarter. Though Valve had expected to supply several Index orders in time for the release of Alyx, the COVID-19 pandemic limited their supply chain. Valve's Greg Coomer said Valve knew many people would not play Alyx on launch and that its audience was "relatively small right now". Newell described it as a "forward investment" into long-term technologies. In 2021, PCGamesN wrote that though it was "artfully crafted", Alyx had had little cultural impact. As of December 2024, Alyx had sold more than two million copies.
===== United States ===== Intravenous injection – Depacon by Abbott Laboratories. Syrup – Depakene by Abbott Laboratories. (Note: Depakene capsules are valproic acid). Depakote tablets are a mixture of sodium valproate and valproic acid. Tablets – Eliaxim by Bial.
In 1969, the dictator Francisco Franco designated Juan Carlos de Borbón as his successor "by title of king" with the title of Prince of Spain, by virtue of the Law of Succession to the Headship of the State of 1947. After Franco's death on November 20, 1975, the Regency Council assumed interim rule. Two days later, Juan Carlos I was proclaimed king before the Francoist Cortes. He delivered a speech in which he avoided referencing Franco's triumph in the Spanish Civil War and in which, after expressing his "respect and gratitude" to Franco, he stated that he intended to reach "an effective consensus of national concord". In this way, he made it clear that he did not support the pure "immobilist continuism" advocated by the búnker ─ which defended the perpetuation of Francoism under the monarchy established by Franco, following the model established in the Organic Law of the State of 1967─ but with a message to the Army to face the future with "serene tranquility" that hinted that the reform would be made from the regime's own institutions. The most enthusiastic round of applause from the Cortes, however, was not for the new king but for Franco's family present at the ceremony. The anti-Franco opposition received the king's speech with coldness. The ratification of Carlos Arias Navarro as President of the Government caused enormous disappointment, barely mitigated by the appointment of Torcuato Fernández Miranda, former tutor to the prince, as the new President of the Cortes and of the Council of the Realm, key institutions in the framework left by the Franco dictatorship.
Sources: en.wikipedia.org
Next, an epimerization domain changes the stereochemistry of L-alanine (L-Ala) into D-alanine (D-Ala). CesB is a 305 kDa heterodimer protein composed of CesB1 and CesB2 modules. CesB1 behaves almost identically to CesA1, where ketoisocaproic acid was added and reduced; however, the substrate α-ketoisovaleric acid is reduced to L- α-hydroxyisovaleric acid (L-HIV). Additionally, a condensation domain at the end of CesA (beyond CesA2) facilitates the ester formation between L-HIV and the D-HIC-D-Ala peptide. Next, CesB2 adds L-valine (L-Val) to the adenylation domain, and the condensation domain facilitates the nucleophilic attack of the amine on L-Val onto the D-HIC-D-Ala-L-HIV thioester, which creates a D-HIC-D-Ala-L-HIV-L-Val tetrapeptide on the thiolation domain of CesB2. Finally, the final thioesterase domain combines three units of the aforementioned tetrapeptide between the α-hydroxyl group of D-HIC and the thioester of a L-Val of another tetrapeptide. Ultimately, three esters are formed during this cyclization of 3 tetrapeptides. The resulting cyclic depsipeptide, which contains alternating units of esters and amides, is cereulide.
=== miRNA === MicroRNAs (miRNAs) have complementary sequences in the 3' UTR and 5' UTR of target mRNAs of protein-coding genes, and cause mRNA cleavage or repression of translational machinery. In diseased vascular vessels, miRNAs are dysregulated and highly expressed. miR-33 is found in cardiovascular diseases. It is involved in atherosclerotic initiation and progression including lipid metabolism, insulin signaling and glucose homeostatis, cell type progression and proliferation, and myeloid cell differentiation. They found in rodents that the inhibition of miR-33 raises HDL-C levels, and miR-33 expression is down-regulated in humans with atherosclerotic plaques. miR-33a and miR-33b are located on intron 16 of human sterol regulatory element-binding protein 2 (SREBP2) gene on chromosome 22 and intron 17 of SREBP1 gene on chromosome 17. miR-33a/b regulates cholesterol/lipid homeostasis by binding in the 3'UTRs of genes involved in cholesterol transport, such as ATP binding cassette (ABC) transporters, and enhances or represses their expression. Studies have shown that ABCA1 mediates cholesterol transport from peripheral tissues to Apolipoprotein-1. It is also important in the reverse cholesterol transport pathway, where cholesterol is delivered from peripheral tissue to the liver, where it can be excreted into bile or converted to bile acids before excretion. Therefore, ABCA1 prevents cholesterol accumulation in macrophages. By enhancing miR-33 function, ABCA1 levels decrease, leading to decreased cellular cholesterol efflux to apoA-1.
== Technological achievements == In addition to being credited with the development of one of the first anti-virus programs, "Vaccine", Tippett pioneered and commercialized a string of now-common technologies including what is now called the "Recovery Disk," processor image signatures, using hash-tables for trusted file execution and anomaly detection, aspects of mail merge and "un-do." He ran a bulletin board system for CP/M software before the first IBM PC was created and was president of the Cleveland Osborne Group (a user group for the computers of the Osborne Computer Corporation) in the early 1980s. As chief scientist for ICSA.net, Tippett was one of a handful of experts to identify and address the ILOVEYOU virus that broke in May 2000 and provided key information to the Department of Justice about David Smith, the writer of the Melissa virus. He was featured on the cover of the August 2000 issue of Time Digital magazine.
While transformed, he wields the D-Sword Vega (ディーソード・ベガ, Dī Sōdo Bega), which possesses a gun function and allows him to perform the Vega Tornado Slash (ベガトルネードスラッシュ, Bega Torunēdo Surasshu) attack and the Vega Slash (ベガスラッシュ, Bega Surasshu) finisher. He also rides the S.P.D. Helicopter (S.P.D.ヘリコプター, Esu Pī Dī Herikoputā). Doggie Kruger is voiced by Tetsu Inada (稲田 徹, Inada Tetsu).
Venturing beyond Cumana, Humboldt and Bonpland received hospitality from local mulatto peasants, who were unfamiliar with their European origins but generous nonetheless. During one such excursion, they learned of a local laborer named Francisco Loyano, who had reportedly nursed a child with his own milk due to unusual lactation, a fact confirmed by local witnesses and Bonpland’s examination. By early September, acclimatized and prepared, Humboldt and Bonpland embarked on their first significant inland journey to the Cumanagoto tribe missions in the mountains south of Cumana. The challenging route led them through dense rainforest, across mountain streams, and along precipitous paths, where they marveled at the forest’s grandeur and the diversity of wildlife. The mission headquarters at Caripe, a cool, spring-fed location surrounded by mountains, became their base. Humboldt was surprised to find the Capuchin monks welcoming and tolerant, despite religious differences, and noted the presence of contemporary scientific texts among them. Daily life at Caripe was a blend of scientific work and cultural observation. Humboldt and Bonpland collected plants, studied the Cumanagoto language, and documented local customs, including the children’s consumption of large millipedes. Meals at the monastery reflected the monks’ sacrifices, as they often gave up their own rations for the guests. The soundscape was dominated by howler monkeys, especially during rain, and opportunities for astronomical observation were rare due to persistent mist.
Sources: en.wikipedia.org
Liquid chromatography combined with mass spectrometry is the most common approach. Digestion followed by peptide mapping verifies the sequence and modification sites. Results are judged against a reference standard or a theoretically calculated mass.
Lower temperatures slow most degradation routes, and storage at minus twenty degrees Celsius or below is standard for lyophilized material. Repeated warming and cooling imposes stress on the molecule. Dissolved samples deteriorate faster and are usually handled over shorter periods.
It normally reflects the relative chromatographic area of the principal peak. It does not capture every possible impurity or demonstrate biological function. Additional methods are required to describe a sample completely.
It acts as an agonist at both the GIP and GLP-1 receptors, two related class B G protein-coupled receptors. This dual activity distinguishes it from single-receptor GLP-1 agonists. The clinical consequences of engaging both receptors are still being characterized.